Clinical Trials Directory

Trials / Completed

CompletedNCT04313257

Monocular Action Video Game Treatment of Amblyopia

Monocular Action Video Game Versus Passive Occlusion In The Treatment Of Amblyopia: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Universitat Politècnica de Catalunya · Academic / Other
Sex
All
Age
4 Years – 10 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments.

Detailed description

Amblyopia is the condition in which there is a decrease in monocular visual acuity or, less frequently, binocular, in absence of structural anomalies or ocular pathology. It is a reversible condition that affects up to 5% of the population, and that is the result of an abnormal visual experience during the most sensitive period of visual development. The aim of this study is reviewing, analyzing and, if applicable, updating the current treatment model for amblyopia. A randomized clinical trial will be performed to evaluate the effectiveness of the monocular treatment with action video-games in comparison with the occlusion therapy alone in amblyopic patients, and the satisfaction with the different evaluated treatments. The participants will be distributed in two groups. The first group will include those participants who will follow a daily occlusive treatment and the second group will include patients who will be treated with monocular therapy with video-games.The sample will include subjects between 4 to 10 years old with a diagnosis of refractive and / or strabismic amblyopia.

Conditions

Interventions

TypeNameDescription
OTHERMonocular Active OcclusionOcclusion treatment of one hour daily with action video game.
OTHERMonocular Passive OcclusionOcclusion treatment of two hour daily.

Timeline

Start date
2019-09-17
Primary completion
2023-01-16
Completion
2023-01-16
First posted
2020-03-18
Last updated
2023-03-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04313257. Inclusion in this directory is not an endorsement.